Seagen

Seagen

Seagen is committed to advancing late-stage clinical trials and expanding the development of its portfolio both in and outside the U.S. to better the health of people with cancer. We are dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. We are focused on discovering, developing and commercializing a new generation of transformative cancer medicines and empowered antibody-based therapies that have the potential to change the foundation of treatment for people with cancer. 

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Seagen
Seagen The Charter Building, Charter Place Uxbridge UB8 1GJ United Kingdom
Get directions

CPD Subsectors

Medical
Scientific Research
Scientific Organisations
Medical Equipment
Health & Wellbeing